Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zealand Pharma A/S ADR (ZEAL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 562,879
  • Shares Outstanding, K 30,787
  • Annual Sales, $ 6,020 K
  • Annual Income, $ 92,080 K
  • 60-Month Beta 2.26
  • Price/Sales 93.60
  • Price/Cash Flow 6.06
  • Price/Book 3.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +63.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.10 +13.56%
on 03/19/19
20.00 -8.58%
on 04/08/19
+2.61 (+16.62%)
since 03/18/19
3-Month
14.00 +30.59%
on 02/08/19
20.00 -8.58%
on 04/08/19
+3.34 (+22.38%)
since 01/18/19
52-Week
11.51 +58.84%
on 11/14/18
20.00 -8.58%
on 04/08/19
+3.28 (+21.89%)
since 04/18/18

Most Recent Stories

More News
Report: Developing Opportunities within Apergy, vTv Therapeutics, Arcimoto, Lipocine, Zealand Pharma A/S, and AquaBounty Technologies -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Apergy Corporation (NYSE:APY), vTv...

AQB : 2.26 (+2.26%)
VTVT : 1.30 (-1.14%)
FUV : 3.80 (-1.81%)
APY : 41.00 (+0.32%)
LPCN : 1.86 (-3.12%)
ZEAL : 18.28 (-0.09%)
Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases

--- Agreement provides Alexion with exclusive worldwide licenses for one preclinical target, with option for up to three additional targets, in the complement pathway -

ALXN : 126.01 (+0.08%)
ZEAL : 18.28 (-0.09%)
Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress

Company announcement - No. 03 / 2019

ZEAL : 18.28 (-0.09%)
Blog Exposure - Zealand's End-of-Phase-2 Meeting with FDA Confirmed the Path Forward for Phase-3 Program of Glepaglutide for Short Bowel Syndrome

Stock Monitor: Cytokinetics Post Earnings Reporting

ZEAL : 18.28 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ZEAL with:

Business Summary

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.

See More

Key Turning Points

2nd Resistance Point 18.36
1st Resistance Point 18.32
Last Price 18.28
1st Support Level 18.26
2nd Support Level 18.25

See More

52-Week High 20.00
Last Price 18.28
Fibonacci 61.8% 16.76
Fibonacci 50% 15.76
Fibonacci 38.2% 14.75
52-Week Low 11.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar